Medtronic Ups Stake In China Cardiac Market With LifeTech Investment
This article was originally published in The Gray Sheet
Executive Summary
The $66 million deal gives Medtronic a significant stake in LifeTech, a Chinese developer of minimally invasive devices, including balloon catheters, delivery systems, occluders and stent graft systems.